Skip to content

comparison of therapeutic methods of tinnitus

Comparison two therapeutic methods (burst repetitive transcranial magnetic stimulation with high frequency repetitive transcranial magnetic stimulation) on compliants of patient with chronic tinnitus.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201112218438N1
Enrollment
80
Registered
2012-01-17
Start date
2011-12-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tinnitus. tinnitus

Interventions

Intervention 1: intervention group: burst repetitive transcranial magnetic stimulation with50 hz frequency and for 40 second on each auditory cortex that after 15 minute it will be repeated . it will
Treatment - Devices
intervention group: burst repetitive transcranial magnetic stimulation with50 hz frequency and for 40 second on each auditory cortex that after 15 minute it will be repeated . it will be done weekly
control group : tonic repetitive transcranial magnetic stimulation with 10hz frequency ,1000 pulse and 25 seconds rest time only on left auditory cortex.

Sponsors

Research deputy of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:18-75 age? innitus for six month. Exclusion criteria :menier? flacuating hearing loss? history of epilepcy ? head truma ? brain surgery ? pace maker? using of anticonvulsant or anti psychotic? regular using of banzodiazepine ?pregnant women ? history of suicide? disease that has interaction with tratment .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of tinnitus. Timepoint: before treatment, after treatment ,4week after treatment. Method of measurement: Visual analog scale, tinnitus questionnaire.

Secondary

MeasureTime frame
Complication including headache. Timepoint: after treatment. Method of measurement: check list.;Complication including vertigo. Timepoint: after treatment. Method of measurement: check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyedeh- Maryam Yazdi -Bahri

Tehran university of Medical Sciences and Health Services

m-yazdi@razi.tums.ac.ir+98 21 7762 9780

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026